These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7694027)

  • 1. Altered cerebrospinal fluid amino acid pattern in the anorexia of aging: relationship with biogenic amine metabolism.
    Martinez M; Arnalich F; Vazquez JJ; Hernanz A
    Life Sci; 1993; 53(21):1643-50. PubMed ID: 7694027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of anorectic cytokine levels from plasma and cerebrospinal fluid in idiopathic senile anorexia.
    Martinez M; Arnalich F; Hernanz A
    Mech Ageing Dev; 1993 Dec; 72(2):145-53. PubMed ID: 8152318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.
    Pilotto A; Blau N; Leks E; Schulte C; Deuschl C; Zipser C; Piel D; Freisinger P; Gramer G; Kölker S; Haas D; Burgard P; Nawroth P; Georg H; Scheffler K; Berg D; Trefz F
    J Inherit Metab Dis; 2019 May; 42(3):398-406. PubMed ID: 30706953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
    Hagenfeldt L; Bjerkenstedt L; Edman G; Sedvall G; Wiesel FA
    J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls.
    Bjerkenstedt L; Edman G; Hagenfeldt L; Sedvall G; Wiesel FA
    Br J Psychiatry; 1985 Sep; 147():276-82. PubMed ID: 2415198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
    Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
    Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
    Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
    Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroamine related compounds in the CSF of hydrocephalic rabbits.
    Olmstead CE; Lazareff JA; Orlino EN; Fluharty AL; Faull KF; Peacock WJ; Wehby-Grant MC; Gayek RJ; Fisher RS
    Neuroreport; 1995 Sep; 6(13):1769-72. PubMed ID: 8541478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup.
    Shaywitz BA; Anderson GM; Cohen DJ
    Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-amine metabolites in depression, dementia and in controls.
    Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
    Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
    Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
    Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
    Botez MI; Young SN
    Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia.
    Martinez M; Hernanz A; Gómez-Cerezo J; Peña JM; Vazquez JJ; Arnalich F
    Regul Pept; 1993 Dec; 49(2):109-17. PubMed ID: 7907801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma.
    Seegal RF; Brosch KO; Bush B
    J Chromatogr; 1986 Apr; 377():131-44. PubMed ID: 2423546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on biogenic amines and their acidic metabolites in brain and cerebrospinal fluid of rats.
    Elo HA; MacDonald E
    Arch Toxicol; 1989; 63(2):127-30. PubMed ID: 2471493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL; Young SN; Garelis E; Lal S
    Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
    Kärkelä J; Scheinin M
    J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.